2025 Annual Report: Advancing DFU and CLTI Research in Vascular Wound Care
Summary:** The 2025 annual report from a vascular research group highlights progress in diabetic foot ulcer (DFU) and chronic limb-threatening ischemia (CLTI) management, including trials for endovascular revascularization, EVAR/FEVAR, and amputation prevention. Key studies evaluate outcomes in DFUs under pressure, with pressure ulcer prevention integrated into pressure management. The report emphasizes multidisciplinary approaches to reduce amputation rates and improve healing in high-risk patients, with data from 2024 trials informing 2025 priorities for wound care innovation.
Key Highlights:
- DFU Focus: Trials on pressure-related ulcers and neuropathy, integrating vascular support for better closure.
- CLTI: Endovascular vs. bypass for limb salvage; EVAR/FEVAR for aneurysm-related wounds.
- Pressure Ulcers: Prevention strategies in immobilized patients, linked to DFU comorbidities.
- Outcomes: Reduced amputations through early intervention; 2024 data shows 20% improvement in healing rates.
- Future: 2025 trials on biomaterials and telemedicine for remote DFU monitoring.
Keywords: DFU research, CLTI, amputation prevention, vascular trials, pressure ulcers